TNFRSF4 and cancer: We recommend, OX40 and OX40L gene expressional levels should be estimated in larger cohort with pretreatment and posttreatment cancer patients for comparative analysis along with the phenotyping of cells expressing these costimulatory molecules because of their controversial role in anticancer immunity.